Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study.

Otto F, Kliushnikova D, Radlberger R F, Yasaroglu S, Moser T, Harrer A, Kratzer K, Hitzl W, Gradl C, Schmidauer M, et al.

Ann Clin Transl Neurol. 2026 Jul 28. PMID: 42522253. Abstract